Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Trio of Factors Behind Falling Heart Disease Mortality

By HospiMedica International staff writers
Posted on 16 Mar 2016
Changes in smoking prevalence, serum cholesterol, and systolic blood pressure (BP) have been the major reason behind falling coronary heart disease (CHD) mortality over the past 40 years, according to a new study.

Researchers at the Finnish National Institute for Health and Welfare (Helsinki, Finland) conducted a population-based observational study to estimate how changes in the main risk factors of cardiovascular disease (CVD) can explain the reduction in CHD mortality observed among the working age population in eastern Finland. More...
Participants included 34,525 men and women aged 30–59 years of age who participated in national studies between 1972 and 2012. The main outcome measures were predicted and observed age standardized mortality due to CHD.

The results showed that during the 40 years of the study, CHD mortality decreased by 82% and 84% among men and women aged 35–64 years, respectively. During this time, levels of the three major CVD risk factors decreased, except for a small increase in serum cholesterol levels between 2007 and 2012. Since the mid-1980s, the observed reduction in mortality has been larger than predicted, with about two thirds of the reduction explained by changes in the three main risk factors, and the remaining third by other factors. The study was published on March 1, 2016, in BMJ.

“Although secondary prevention and treatment protocols have markedly developed in recent decades, primary prevention and reduction in levels of the main classical factors contributing to cardiovascular risk should still be considered as the main strategy to reduce disease burden and mortality due to coronary heart disease,” concluded lead author Pekka Jousilahti, MD, PhD. “The changes in the three target risk factors during the first ten years of the study contributed to nearly all of the observed mortality reduction.”

Mortality from CHD started to increase in Finland in the 1950s, associated with an increasing standard of living, dietary causes, and other lifestyle changes. In the late 1960s, this mortality was the highest in the world, and was particularly high among working aged men in the eastern part of the country. As a result, the North Karelia Project was launched in 1972, with the aim of reducing the extremely high mortality from CHD by focusing on behavioral change through community action and participation, supported by screening of high risk individuals and medical treatment.

Related Links:

Finnish National Institute for Health and Welfare



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.